dr sara m. tolaney discusses the role of adjuvant therapy in her2-positive breast cancer
Published 6 years ago • 267 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
2:04
dr sara m. tolaney: standard of care, novel approaches for treatment of her2-positive breast cancer
-
1:48
dr. tolaney on the evolution of adjuvant treatment for her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
4:26
dr. sara tolaney on adjuvant t-dm1 vs paclitaxel and trastuzumab for stage i her2 breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
29:21
new advances and opportunities for improvement in hr /her2- early breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:47
evaluating the role of neoadjuvant endocrine therapy in breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer